AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

Clinical trial NCT00467025 · COMPLETED

Trial details

NCT number: NCT00467025
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Renal Cell Carcinoma

Start date: 2007-05-01
Primary completion: 2010-04-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.